Search clinical trials for: TMC435 Escitalopram

Total 666 results

Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C112 - Interaction Trial With Antidepressants

Hepatitis C Virus
Janssen R&D Ireland

Completed

A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.

Healthy Volunteers

United Kingdom
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study

Hepatitis C
St. Luke's-Roosevelt Hospital Center
Forest Laboratories

Completed

Escitalopram in the Treatment of Dysthymic Disorder, Double Blind

Dysthymic Disorder

United States
Janssen Research & Development, LLC

Completed

A Study to Examine the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of TMC435 in Healthy Chinese Participants

Healthy

China
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir

Hepatitis C Virus
University of Copenhagen
Lundbeck Foundation; Glostrup University Hospital, Copenhagen

Completed

The Effects of Increased Central Serotonergic Activity on Information Processing

Healthy Volunteers

Denmark
First Affiliated Hospital of Zhejiang University

Recruiting

Development and Application of Comprehensive Intervention Techniques for Adolescent Depression

Adolescent | Depressive Disorder

China
University of Nebraska

Recruiting

A Study Utilizing Escitalopram in Glioma Patients

Glioma | Glioma of Brain

United States
Mayo Clinic
National Institute of General Medical Sciences (NIGMS); National Center for...

Completed

Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram (PGRN-SSRI)

Depression

United States
Centre for Addiction and Mental Health
Queen's University

Completed

Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression

Depression

Canada
Shanghai 7th People's Hospital

Not yet recruiting

Acupuncture and Escitalopram for Treating Major Depression Clinical Study (AE-TMDCS)

Depressive Disorder, Major

China
Shanghai Mental Health Center
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression

Depression

China
Shanghai Mental Health Center

Recruiting

A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment

Major Depressive Disorder

China
University of Pennsylvania
Washington University School of Medicine

Completed

Escitalopram Effects on CSF Amyloid Beta

Amyloid Beta Protein

United States
Ryerson University

Unknown

Behavioral Insomnia Therapy For Those With Insomnia and Depression

Insomnia | Major Depressive Disorder

Canada
Johns Hopkins University
Medical University of South Carolina; University of South Carolina; University... and other collaborators

Recruiting

Escitalopram and Language Intervention for Subacute Aphasia (ELISA)

Stroke | Aphasia

United States
University of California, Los Angeles

Unknown

Brain Mechanisms and Targeting Insomnia in Major Depression

Insomnia | Major Depressive Disorder

United States
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
Oregon Health and Science University
Forest Laboratories

Completed

Circadian Effects of Escitalopram

Depression

United States
Samsung Medical Center
H. Lundbeck A/S

Unknown

Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning

Depression | Adverse Reaction to Drug | Continuous Antidepressant Abuse

Korea, Republic of
Duke University
Forest Laboratories

Completed

Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features

Atypical Depression

United States
Markus KOSEL
University Hospital, Geneva; H. Lundbeck A/S; University Hospital, Basel, Switzerland and other collaborators

Terminated

EScitalopram PIndolol ONset of Action (ESPION)

Unipolar Depression

Switzerland
Stanford University
National Institute of Mental Health (NIMH)

Completed

Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

Insomnia | Major Depressive Disorder

United States
Janssen R&D Ireland

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients (RESTORE)

Hepatitis C

France, Belgium
Tibotec Pharmaceuticals, Ireland

Completed

TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers

Hepatitis C

Hong Kong
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435

Hepatitis C Virus

United States
Massachusetts General Hospital

Completed

Biological Markers of Response to Treatment in Major Depressive Disorder

Major Depressive Disorder
Milton S. Hershey Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

Insomnia | Panic Disorder

United States
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Treatment of Depression in Adults

Depression

United States, Italy
NYU Langone Health
National Institute on Aging (NIA)

Recruiting

Aβ Dynamics in LLMD

Alzheimer Disease | Major Depressive Disorder

United States
KRL Hospital, Islamabad
Dow University of Health Sciences; Khyber Medical College, Peshawar; Quaid-e-Azam...

Completed

Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder

Major Depressive Disorder

Pakistan
Laureate Institute for Brain Research, Inc.

Terminated

Adherence to Antidepressant Treatment in Subjects With Depression

Depression

United States
University of Texas Southwestern Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon (TAKEDA)

Insomnia | Major Depressive Disorder

United States
University of Texas Southwestern Medical Center
Forest Laboratories

Completed

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Severe Asthma | Moderate or Severe Major Depressive Disorder

United States
University of Washington
National Institutes of Health (NIH); Forest Laboratories

Terminated

Sinusitis and Facial Pain Disorders Anti-Depression Trial (SFPAT)

Depression | Chronic Sinusitis | Facial Pain Disorder

United States
Janssen R&D Ireland

Completed

A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients

Healthy Male Participants

Belgium
Janssen R&D Ireland

Completed

A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study

Hepatitis C

United States, Australia, France, Ukraine, United Kingdom, Belgium, Germany, Spain, Israel, Portugal, Bulgaria, Netherlands, Canada, New Zealand, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Poland, Romania, Mexico
H. Lundbeck A/S

Completed

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Major Depressive Disorder

Austria, Russian Federation
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Escitalopram

Obesity, Morbid

Norway
Max Planck Institute for Human Cognitive and Brain...
University of Leipzig

Unknown

Serotonin and Motor Plasticity

Healthy Controls

Germany
Massachusetts General Hospital
Mclean Hospital

Completed

Brain GABA Levels and Treatment Response in Major Depressive Disorder

Major Depressive Disorder

United States
Medical University of Vienna

Completed

Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders (MAN-BIOPSY)

Major Depressive Disorder (MDD) | Anxiety Disorder

Austria
University of British Columbia

Terminated

Escitalopram and Depression in Elderly Alzheimer's Patients

Depressive Disorder

Canada
Assistance Publique - Hôpitaux de Paris

Completed

Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension

Pulmonary Hypertension

France
Tibotec BVBA

Completed

VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram

Hepatitis C
University of Ottawa
H. Lundbeck A/S

Unknown

Treatment Youth With Obsessive-Compulsive Disorder

Obsessive Compulsive Disorder

Canada
Icahn School of Medicine at Mount Sinai
Forest Laboratories

Completed

Efficacy of Escitalopram in the Treatment of Internet Addiction

Internet Addiction
Sheba Medical Center

Unknown

Efficacy Study of Escitalopram for Depression in Patients With Diabetes (EFDID)

Diabetes Mellitus | Major Depression

Israel

Search clinical trials for: TMC435 Escitalopram

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations